TY  - JOUR
A1  - Vendelova, Emilia
A1  - Ashour, Diyaaeldin
A1  - Blank, Patrick
A1  - Erhard, Florian
A1  - Saliba, Antoine-Emmanuel
A1  - Kalinke, Ulrich
A1  - Lutz, Manfred B.
T1  - Tolerogenic transcriptional signatures of steady-state and pathogen-induced dendritic cells
JF  - Frontiers in Immunology
N2  - Dendritic cells (DCs) are key directors of tolerogenic and immunogenic immune responses. During the steady state, DCs maintain T cell tolerance to self-antigens by multiple mechanisms including inducing anergy, deletion, and Treg activity. All of these mechanisms help to prevent autoimmune diseases or other hyperreactivities. Different DC subsets contribute to pathogen recognition by expression of different subsets of pattern recognition receptors, including Toll-like receptors or C-type lectins. In addition to the triggering of immune responses in infected hosts, most pathogens have evolved mechanisms for evasion of targeted responses. One such strategy is characterized by adopting the host's T cell tolerance mechanisms. Understanding these tolerogenic mechanisms is of utmost importance for therapeutic approaches to treat immune pathologies, tumors and infections. Transcriptional profiling has developed into a potent tool for DC subset identification. Here, we review and compile pathogen-induced tolerogenic transcriptional signatures from mRNA profiling data of currently available bacterial- or helminth-induced transcriptional signatures. We compare them with signatures of tolerogenic steady-state DC subtypes to identify common and divergent strategies of pathogen induced immune evasion. Candidate molecules are discussed in detail. Our analysis provides further insights into tolerogenic DC signatures and their exploitation by different pathogens.
KW  - bacteria
KW  - helminths
KW  - immune evasion
KW  - mycobacteria
KW  - transcriptional profiling
KW  - tolerogenic dendritic cells
KW  - steady-state dendritic cells
Y1  - 2018
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-175636
VL  - 9
IS  - 333
ER  - 
TY  - JOUR
A1  - Silva-Vilches, Cinthia
A1  - Pletinckx, Katrien
A1  - Lohnert, Miriam
A1  - Pavlovic, Vladimir
A1  - Ashour, Diyaaeldin
A1  - John, Vini
A1  - Vendelova, Emilia
A1  - Kneitz, Susanne
A1  - Zhou, Jie
A1  - Chen, Rena
A1  - Reinheckel, Thomas
A1  - Mueller, Thomas D.
A1  - Bodem, Jochen
A1  - Lutz, Manfred B.
T1  - Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion
JF  - PLoS ONE
N2  - Immature or semi-mature dendritic cells (DCs) represent tolerogenic maturation stages that can convert naive T cells into Foxp3\(^{+}\) induced regulatory T cells (iTreg). Here we found that murine bone marrow-derived DCs (BM-DCs) treated with cholera toxin (CT) matured by up-regulating MHC-II and costimulatory molecules using either high or low doses of CT (CT\(^{hi}\), CT\(^{lo}\)) or with cAMP, a known mediator CT signals. However, all three conditions also induced mRNA of both isoforms of the tolerogenic molecule cytotoxic T lymphocyte antigen 2 (CTLA-2α and CTLA-2β). Only DCs matured under CT\(^{hi}\) conditions secreted IL-1β, IL-6 and IL-23 leading to the instruction of Th17 cell polarization. In contrast, CT\(^{lo}\)- or cAMP-DCs resembled semi-mature DCs and enhanced TGF-β-dependent Foxp3\(^{+}\) iTreg conversion. iTreg conversion could be reduced using siRNA blocking of CTLA-2 and reversely, addition of recombinant CTLA-2α increased iTreg conversion in vitro. Injection of CT\(^{lo}\)- or cAMP-DCs exerted MOG peptide-specific protective effects in experimental autoimmune encephalomyelitis (EAE) by inducing Foxp3\(^{+}\) Tregs and reducing Th17 responses. Together, we identified CTLA-2 production by DCs as a novel tolerogenic mediator of TGF-β-mediated iTreg induction in vitro and in vivo. The CT-induced and cAMP-mediated up-regulation of CTLA-2 also may point to a novel immune evasion mechanism of Vibrio cholerae.
KW  - small interfering RNAs
KW  - toxins
KW  - regulatory T cells
KW  - T cells
KW  - cytokines
KW  - cholera
KW  - cell differentiation
KW  - immune evasion
Y1  - 2017
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-158244
VL  - 12
IS  - 7
ER  -